26.03.2019
Rückzug einzelner Chargen von Ketasin 100 ad us. vet., Injektionslösung, bis auf Stufe Detailhandel
26.03.2019
Befristete Bewilligung zum Vertrieb in englischer Aufmachung
20.03.2019
Vorsichtsmassnahme: geänderte Lagertemperatur
15.03.2019
Risiko von Leberschädigungen: weitere Anpassung der Arzneimittelinformation
15.03.2019
Befristete Bewilligung zum Vertrieb in französischer Aufmachung
In focus
04.12.2018
The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019
Direct links
Communications regarding the safety of medicines
Select from the list…
HPC/DHPC
Publication of safety measures (FSCA)
Product groups, services
Select from the list…
Authorised narcotics
Authorisations
Penal Law
Swissmedic Journal
Certificates
Legal matters
Stay up to date
Our news subscription service provides on-going information via e-mail.
Incident reporting
Medicines
Reporting undesirable effects
Medical devices
Reporting incidents & FSCAs
Featured
In this edition:
Isotretinoin and DOAC – Updates
Confusion between amphotericin B formulations
Guest articles: RPVC Zurich and RPVC Ticino
Quality Assurance in Transfusion Practice
Statistical Review 2017
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
For further information...
